Short Interest in ProtoKinetix, Incorporated (OTCMKTS:PKTX) Declines By 96.0%

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the target of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 400 shares, a drop of 96.0% from the January 31st total of 10,000 shares. Based on an average daily trading volume, of 408,500 shares, the days-to-cover ratio is currently 0.0 days.

ProtoKinetix Price Performance

Shares of OTCMKTS:PKTX traded up $0.00 during mid-day trading on Friday, reaching $0.01. 241,181 shares of the company’s stock were exchanged, compared to its average volume of 177,778. ProtoKinetix has a twelve month low of $0.01 and a twelve month high of $0.02. The business’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.01.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.